Nanoviricides, Inc. (NNVC) SEC Filings — 2025
7 SEC filings for Nanoviricides, Inc. (NNVC) in 2025.
Filings
- Nanoviricides, Inc. 8-K Filing — 8-K · Nov 26, 2025
- NanoViricides Narrows Q1 Loss Amid Cash Crunch, Eyes NV-387 Milestones — 10-Q · Nov 14, 2025
- NanoViricides Sets Nov. 8 Annual Meeting; Diwan Re-election, Say-on-Pay on Agenda — DEF 14A · Oct 8, 2025
- NanoViricides, Inc. Files 8-K on Officer/Director Changes — 8-K · Oct 1, 2025
- NanoViricides' Lead Drug NV-387 Clears Phase I, Eyes Broad-Spectrum Antiviral Market — 10-K · Sep 29, 2025
- NanoViricides, Inc. Files Q3 2025 10-Q — 10-Q · May 15, 2025
- NanoViricides Reports Q2 Results — 10-Q · Feb 14, 2025